Press Releases

Date Title and Summary Additional Formats
Toggle Summary Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
SOUTH SAN FRANCISCO, Calif., March 27, 2017 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of Directors.   Barthelemy brings over 25 years of health care industry experience to the Fluidigm Board, having served in
View HTML
Toggle Summary Fluidigm to Present at Cowen and Company 37th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., February 23, 2017 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, will present at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 9:20 am ET in Boston, Massachusetts.
View HTML
Toggle Summary Fluidigm Announces Q4 And Full Year 2016 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced its financial results for the fourth quarter and full year ended December 31, 2016.  Total revenue for the fourth quarter of 2016 was $25.1 million, an increase of 13% from
View HTML
Toggle Summary Fluidigm to Report Q4 and Full Year 2016 Financial Results
SOUTH SAN FRANCISCO, Calif., January 25, 2017 — Fluidigm Corporation (NASDAQ:FLDM) today announced it will report fourth quarter and full year 2016 financial results on Wednesday, February 8, 2017, after the financial markets close. Chris Linthwaite, President and Chief Executive Officer, and
View HTML
Toggle Summary Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year
Ended December 31, 2016
View HTML
Toggle Summary Fluidigm Introduces a New Medium-Cell High-Throughput Integrated Fluidic Circuit
With Higher Single-Cell Capture Performance on the C1
View HTML
Toggle Summary Fluidigm to Present at Piper Jaffray 28th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., November 29, 2016 – Fluidigm Corporation (NASDAQ:FLDM) today announced that it will webcast the company’s presentation at the Piper Jaffray 28th Annual Healthcare Conference in New York City on November 30, 2016. Chris Linthwaite, President and Chief Executive Officer,
View HTML
Toggle Summary Fluidigm Corporation Adopts Tax Benefit Preservation Plan
To Protect its Net Operating Loss Carryforwards
View HTML
Toggle Summary Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels for Immuno-Oncology
A comprehensive and flexible approach to deeply profile T cell phenotypes and function in immune checkpoint response   SOUTH SAN FRANCISCO, Calif., Nov 10, 2016 – Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of a modular set of high-parameter Maxpar® mass cytometry panels for
View HTML
Toggle Summary Fluidigm and Genomoncology Partner to Provide Automated Oncology NGS Library
Preparation with Molecular Interpretation & Reporting
View HTML